CTC127

N/A

Report date: 2025/12/04 17:44:02

Base Information

Drug NameCTC127
Drug Alias NameCTC127CTC-127
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionAnti-Melanoma-associated antigen 4
TargetsMelanoma-associated antigen 4
Therapy Area/IndicationsGastroesophageal Junction NeoplasmsUrinary Bladder NeoplasmsLung Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCaptain T Cell
China Registration ClassN/A

Develop Information

Active CompaniesCaptain T Cell
Inactive CompaniesN/A
Active IndicationsGastroesophageal Junction NeoplasmsUrinary Bladder NeoplasmsLung Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A